MIPC synthesis is catalyzed by either of two homologous IPC mannosyltransferases, Csg1 and Csh1, which prefer different IPC species as substrates (12, 13) . Cells carrying a double mutation, Δcsg1 Δcsh1, are sensitive to external Ca 2+ (5, 12, 14) , suggesting a role for the GSLs in cellular stress response. We recently demonstrated that the Ca 2+ -binding protein Csg2 (14, 15) , interacts with both Csg1 and Csh1 (12) . Our Δcsg1 Δcsg2 cells had no MIPC synthase activity, and introduction of a Δcsg2 mutation into the Δcsh1 cells also resulted in a significant reduction in activity (12) . Thus, interaction with Csg2 is essential for the activity of Csh1 and is quite important for that of Csg1.
The existence of the Ca 2+ -binding regulatory subunit Csg2 and two different catalytic subunits, Csg1 and Csh1, implies that IPC-to-MIPC conversion is a highly regulated process. However, the exact functions of Csg2
and Ca 2+ in MIPC synthesis remain unclear. In the present study, we report that Csg2 functions in the production, stability, and transport of Csg1 and/or Csh1. In addition, we found that Ca 2+ treatment increases Csg1 levels in a Csg2-dependent manner and enhances MIPC synthesis.
Experimental Procedures
Yeast Strains and Media --Saccharomyces cerevisiae strains used are listed in Table I µM forward primer, and 0.9 µM reverse primer.
The reactions were incubated in a 96-well plate at 95˚C for 10 min, followed by 40 cycles at 95˚C for 15 s, and 60˚C for 1 min. All reactions were run in triplicate.
]DHS labeling assay was performed as described previously (12) . Therefore, we next examined the effects of Csg2 on the glycosylation status of Csg1 and Csh1.
RESULTS

N-glycosylation in Csg1 and
Neither the gel mobility nor protein levels of Csg1-3xFLAG differed in the Δcsg2 cells compared to those in cells bearing the wild-type CSG2 ( Fig. 2A) . In contrast, the broad bands of 55-70 kDa representing Csh1-3xFLAG were completely converted in the Δcsg2 mutant to the 49 kDa band ( Fig. 2A) , which may have the endoplasmic reticulum (ER) "high mannose-type" glycan as discussed below.
We also investigated the glycosylation status of overproduced Csg1 and Csh1. Both proteins were expressed as C-terminally (Fig. 3A) .
As shown in Fig. 3B , the gel mobility of Csg1-His 6 -Myc was unchanged in the Δvan1 cells. In contrast, the broad 55-70 kDa bands of Csh1-His 6 -Myc observed in the wild-type cells were diminished in the Δvan1 mutants, but a 51 kDa band appeared, which may carry an incomplete mannan-type structure (Fig. 3C ).
These results suggest that Csh1 is N-glycosylated with a 'mannan-type' structure, whereas Csg1 may be modified with 'core-type' glycosylation. In contrast, most of Csh1-3xFLAG in the Δcsg2 mutant cells carried N-glycans of the high mannose-type (Csh1-3xFLAG (H)) and co-fractionated with Dpm1 (Fig. 4) and PRB1, which each encodes a major vacuolar protease. In the Δpep4 Δprb1 mutant, the amount of endogenously expressed Csg1-3xFLAG was increased (Fig. 5A ),
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suggesting that Csg1 is delivered to the vacuole for degradation. In addition, the pattern and intensity of this band were similar in the Δcsg2
Δpep4 Δprb1 mutant, indicating that free Csg1 follows the same fate as that of Csg1 complexed with Csg2. The Csh1 level was also increased in the Δpep4 Δprb1 mutant (Fig. 5B) , but strikingly so, implying that it is normally degraded in the vacuole. However, introduction of the Δcsg2 we created an N224Q mutant and examined its glycosylation status. The N224Q mutant Csg1 was detected as a single 46 kDa band, in contrast to wild-type Csg1-His 6 -myc, which was detected as two bands (Fig. 6B ). This result indicates that Asn-224 in Csg1 is indeed modified by glycosylation. Thus, it is highly likely that Csg1 exhibits the same transmembrane topology as Csh1 (Fig. 6C) . and endogenously expressed Csg1-3xFLAG, Csh1-3xFLAG, and Csg2-3xFLAG were examined by immunoblotting following PNGase F treatment to remove N-glycans. Treatment with Ca 2+ did result in dose-dependent increases in Csg1-3xFLAG (Fig. 7A) . However, treatment was less effective in the Δcsg2 cells, suggesting that Csg2 is involved in this process. In contrast, endogenously expressed Csh1-3xFLAG and Csg2-3xFLAG were nearly unchanged by treatment with Ca 2+ (Fig. 7A ).
To investigate whether the increases in protein levels were due to enhanced gene expression, we performed real-time PCR
analyses. The mRNA levels of CSG1 were increased upon treatment with Ca
2+
, in a dose-dependent manner (Fig. 7B) (Fig. 7 A and B) .
Csg2 was found to be involved in the Ca 2+ -dependent Csg1 increase (Fig. 7A ). In addition, overproduction of Csg2 also resulted in an increase in Csg1 level (Fig. 2B) antibodies. Csg1-3xFLAG* and Csh1-3xFLAG* indicate N-glycosylated forms of the proteins. Cells were grown at 30˚C in SC medium lacking histidine and leucine. The fractions of integral membrane proteins were prepared and subjected to immunoprecipitation using anti-Myc antibodies.
Immunoprecipitates were separated by SDS-PAGE, and Csg1-His 6 -Myc and Csh1-His 6 -Myc were detected by immunoblotting with anti-Myc antibodies. Csg1-3xFLAG*, Csh1-3xFLAG*, Csg1-His 6 -Myc*, and Csh1-His 6 -Myc* indicate N-glycosylated forms of the proteins. and SUY80 (CSH1-3xFLAG Δcsg2) cells were grown at 30˚C in YPD medium. Cell lysates were fractionated on a sucrose density gradient. Fractions were analyzed by immunoblotting with anti-FLAG, anti-Anp1, and anti-Dpm1 antibodies. Anp1 and Dpm1 were utilized as specific markers for the Golgi and ER, respectively. Csh1-3xFLAG (M) and Csh1-3xFLAG (H) indicate proteins carrying N-glycans of mannan-type and high mannose-type, respectively. Csg1-3xFLAG and Csh1-3xFLAG were detected by immunoblotting with anti-FLAG M2 antibodies.
Csg1-3xFLAG* and Csh1-3xFLAG* indicate N-glycosylated forms of the proteins; Csg1-3xFLAG** and Csh1-3xFLAG** denote possible degradation products; (•) indicates non-specific bands. Proteins were detected by immunoblotting with anti-FLAG antibodies or, to demonstrate uniform protein loading, anti-Dpm1 antibodies. B, KA31-1A cells were grown for 3 h at 30˚C in YPD medium containing 0, 0.1, 1, 10, or 100 mM CaCl 2 . Total RNA was prepared from these cells, converted to cDNA, and subjected to real-time PCR using primers and probes specific for CSG1, CSH1, CSG2, or ACT1 (actin). Values presented are CSG1, CSH1, and CSG2 mRNA levels relative to the level of ACT1 mRNA. All values represent a mean ± SD from three independent experiments. 
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